适配体作为靶向治疗药物：当前的潜力与挑战 - Suppr

Suppr

超能文献

Aptamers as targeted therapeutics: current potential and challenges.

作者信息

Zhou Jiehua, Rossi John

出版信息

Nat Rev Drug Discov. 2017 Jun;16(6):440. doi: 10.1038/nrd.2017.86. Epub 2017 Apr 28.

DOI:10.1038/nrd.2017.86

PMID:28450742

Abstract

摘要

相似文献

Aptamers as targeted therapeutics: current potential and challenges.

Nat Rev Drug Discov. 2017 Jun;16(6):440. doi: 10.1038/nrd.2017.86. Epub 2017 Apr 28.

Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.

ChemMedChem. 2015 Jan;10(1):39-45. doi: 10.1002/cmdc.201402312. Epub 2014 Oct 2.

Application of aptamers for targeted therapeutics.

Arch Immunol Ther Exp (Warsz). 2013 Aug;61(4):255-71. doi: 10.1007/s00005-013-0227-0. Epub 2013 Apr 7.

Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.

Br J Haematol. 2011 Oct;155(1):3-13. doi: 10.1111/j.1365-2141.2011.08807.x. Epub 2011 Aug 2.

Aptamers as promising molecular recognition elements for diagnostics and therapeutics in the central nervous system.

Nucleic Acid Ther. 2014 Dec;24(6):388-404. doi: 10.1089/nat.2014.0492.

Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.

J Biomech Eng. 2009 Jul;131(7):074005. doi: 10.1115/1.3160763.

Aptamers as drug delivery vehicles.

ChemMedChem. 2014 Sep;9(9):1998-2011. doi: 10.1002/cmdc.201402163. Epub 2014 Aug 11.

Aptamer-based therapeutics of the past, present and future: from the perspective of eye-related diseases.

Drug Discov Today. 2014 Sep;19(9):1309-21. doi: 10.1016/j.drudis.2014.02.009. Epub 2014 Mar 2.

Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers.

Int J Mol Sci. 2016 Mar 11;17(3):358. doi: 10.3390/ijms17030358.

Aptamers and SELEX in Chemistry & Biology.

Chem Biol. 2014 Sep 18;21(9):1055-8. doi: 10.1016/j.chembiol.2014.08.003.

引用本文的文献

Advances in Protein-RNA aptamer recognition and modeling: Current trends and future perspectives.

Curr Opin Struct Biol. 2025 Aug 14;94:103133. doi: 10.1016/j.sbi.2025.103133.

Engineering aptamer-directed phosphatase recruiting chimeras: a strategy for modulating receptor function and overcoming drug resistance.

Nat Commun. 2025 Apr 25;16(1):3919. doi: 10.1038/s41467-025-59098-2.

Bundling gold nanorods with RCA-produced DNA tape into an intelligently reconfigurable nanocluster bomb for multimodal precision cancer therapy.

Mater Today Bio. 2025 Mar 28;32:101718. doi: 10.1016/j.mtbio.2025.101718. eCollection 2025 Jun.

The Potential of RNA Therapeutics in Treating Cardiovascular Disease.

Drugs. 2025 May;85(5):659-676. doi: 10.1007/s40265-025-02173-1. Epub 2025 Apr 2.

Aptamer based immunotherapy: a potential solid tumor therapeutic.

Front Immunol. 2025 Feb 17;16:1536569. doi: 10.3389/fimmu.2025.1536569. eCollection 2025.

Engineered extracellular vesicles with sequential cell recruitment and osteogenic functions to effectively promote senescent bone repair.

J Nanobiotechnology. 2025 Feb 12;23(1):107. doi: 10.1186/s12951-025-03168-6.

DNA Aptamer-Polymer Conjugates for Selective Targeting of Integrin α4β1 T-Lineage Cancers.

ACS Appl Mater Interfaces. 2025 Jan 22;17(3):4543-4561. doi: 10.1021/acsami.4c17788. Epub 2025 Jan 9.

Oligomeric amyloid-β targeted contrast agent for MRI evaluation of Alzheimer's disease mouse models.

Front Pharmacol. 2024 Jun 4;15:1392729. doi: 10.3389/fphar.2024.1392729. eCollection 2024.

Assembling the RNA therapeutics toolbox.

Med Rev (2021). 2024 Mar 20;4(2):110-128. doi: 10.1515/mr-2023-0062. eCollection 2024 Apr.

Robust Fluorometric Aptamer Assay for Direct and Rapid Detection of Clinical Isolates of spec.

Int J Mol Sci. 2024 Mar 19;25(6):3444. doi: 10.3390/ijms25063444.

本文引用的文献

Aptamers as targeted therapeutics: current potential and challenges.

Nat Rev Drug Discov. 2017 Mar;16(3):181-202. doi: 10.1038/nrd.2016.199. Epub 2016 Nov 3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Aptamers as targeted therapeutics: current potential and challenges.

Nat Rev Drug Discov. 2017 Jun;16(6):440. doi: 10.1038/nrd.2017.86. Epub 2017 Apr 28.

Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.

ChemMedChem. 2015 Jan;10(1):39-45. doi: 10.1002/cmdc.201402312. Epub 2014 Oct 2.

Application of aptamers for targeted therapeutics.

Arch Immunol Ther Exp (Warsz). 2013 Aug;61(4):255-71. doi: 10.1007/s00005-013-0227-0. Epub 2013 Apr 7.

Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.

Br J Haematol. 2011 Oct;155(1):3-13. doi: 10.1111/j.1365-2141.2011.08807.x. Epub 2011 Aug 2.

Aptamers as promising molecular recognition elements for diagnostics and therapeutics in the central nervous system.

Nucleic Acid Ther. 2014 Dec;24(6):388-404. doi: 10.1089/nat.2014.0492.

Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.

J Biomech Eng. 2009 Jul;131(7):074005. doi: 10.1115/1.3160763.

Aptamers as drug delivery vehicles.

ChemMedChem. 2014 Sep;9(9):1998-2011. doi: 10.1002/cmdc.201402163. Epub 2014 Aug 11.

Aptamer-based therapeutics of the past, present and future: from the perspective of eye-related diseases.

Drug Discov Today. 2014 Sep;19(9):1309-21. doi: 10.1016/j.drudis.2014.02.009. Epub 2014 Mar 2.

Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers.

Int J Mol Sci. 2016 Mar 11;17(3):358. doi: 10.3390/ijms17030358.

Aptamers and SELEX in Chemistry & Biology.

Chem Biol. 2014 Sep 18;21(9):1055-8. doi: 10.1016/j.chembiol.2014.08.003.

引用本文的文献

Advances in Protein-RNA aptamer recognition and modeling: Current trends and future perspectives.

Curr Opin Struct Biol. 2025 Aug 14;94:103133. doi: 10.1016/j.sbi.2025.103133.

Engineering aptamer-directed phosphatase recruiting chimeras: a strategy for modulating receptor function and overcoming drug resistance.

Nat Commun. 2025 Apr 25;16(1):3919. doi: 10.1038/s41467-025-59098-2.

Bundling gold nanorods with RCA-produced DNA tape into an intelligently reconfigurable nanocluster bomb for multimodal precision cancer therapy.

Mater Today Bio. 2025 Mar 28;32:101718. doi: 10.1016/j.mtbio.2025.101718. eCollection 2025 Jun.

The Potential of RNA Therapeutics in Treating Cardiovascular Disease.

Drugs. 2025 May;85(5):659-676. doi: 10.1007/s40265-025-02173-1. Epub 2025 Apr 2.

Aptamer based immunotherapy: a potential solid tumor therapeutic.

Front Immunol. 2025 Feb 17;16:1536569. doi: 10.3389/fimmu.2025.1536569. eCollection 2025.

Engineered extracellular vesicles with sequential cell recruitment and osteogenic functions to effectively promote senescent bone repair.

J Nanobiotechnology. 2025 Feb 12;23(1):107. doi: 10.1186/s12951-025-03168-6.

DNA Aptamer-Polymer Conjugates for Selective Targeting of Integrin α4β1 T-Lineage Cancers.

ACS Appl Mater Interfaces. 2025 Jan 22;17(3):4543-4561. doi: 10.1021/acsami.4c17788. Epub 2025 Jan 9.

Oligomeric amyloid-β targeted contrast agent for MRI evaluation of Alzheimer's disease mouse models.

Front Pharmacol. 2024 Jun 4;15:1392729. doi: 10.3389/fphar.2024.1392729. eCollection 2024.

Assembling the RNA therapeutics toolbox.

Med Rev (2021). 2024 Mar 20;4(2):110-128. doi: 10.1515/mr-2023-0062. eCollection 2024 Apr.

Robust Fluorometric Aptamer Assay for Direct and Rapid Detection of Clinical Isolates of spec.

Int J Mol Sci. 2024 Mar 19;25(6):3444. doi: 10.3390/ijms25063444.

本文引用的文献

Aptamers as targeted therapeutics: current potential and challenges.

Nat Rev Drug Discov. 2017 Mar;16(3):181-202. doi: 10.1038/nrd.2016.199. Epub 2016 Nov 3.